Baxter International Inc.

NYSE:BAX

Medical - Instruments & Supplies

Healthcare
$26.16 -5.23%

-$1.07 today

Market cap
$13.53B
Beta
0.64
P/E (TTM)
-9.1
EPS (TTM)
-$2.13
Dividend yield
1.03%
52W Low $15.73High $31.76

Volume 4.01M

Average 7.62M

BAX Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Baxter International Inc.NYSE: BAX

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares grows in line with its trailing trend

Q2 FY2026 weighted avg shares of 517M shares rose 0.8% year over year, in line with the +0.7% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.4% from the prior quarter. Over 3 fiscal years it compounded at +0.6% a year.

Context

  • Weighted avg shares increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +0.8% holds above the trailing-twelve-month pace of +0.7%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
517M+0.4% QoQ
Last fiscal yearDec 2025
513M+0.6% YoY
LTMJun 2026
515M+0.7% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.8%——
1 year+0.6%——
3-year CAGR+0.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
513M USD
Year-over-year change
+0.6%
4-year CAGR
+0.5%

Weighted Avg Shares vs competitors

How BAX compares with its peers on the latest reported figures

  • BAX's LTM Jun 2026 weighted avg shares of 515M shares is the 2nd highest of the 5 companies compared; the peer median is 48.69M shares.
  • Its year-over-year change of +0.7% is the 2nd highest of 5, against a peer median of -6.4%.
  • Over three fiscal years its annual growth of +0.6% compares with a peer median of -1.3%.
BAX Competitors Peer median
Weighted Avg Shares for BAX and competitors
Company Period LTM YoY 3-year CAGR
FMSFresenius Medical Care AG & Co. KGaALTM Jun 2026561.53M -36.2%-20.8%
BAXBaxter International Inc.LTM Jun 2026515M +0.7%+0.6%
DVADaVita Inc.LTM Jun 202672.59M -9.5%-2.5%
ICUIICU Medical, Inc.LTM Jun 202624.78M +1.0%+1.1%
INFUInfuSystem Holdings, Inc.LTM Mar 202620.52M -3.4%+0.0%
Peer median (excluding BAX) 48.69M-6.4%-1.3%

Competitors are the stored peer set for BAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue12.15B10.06B10.36B10.64B11.24B
Cost of Revenue7.43B6.51B6.21B6.65B7.87B
Gross Profit4.72B3.55B4.15B3.98B3.38B
Gross Margin38.9%35.3%40.1%37.5%30.1%
Research & Development531M450M518M590M518M
Selling, General & Admin2.85B3.1B2.95B2.97B2.89B
Operating Expenses3.37B6.39B3.44B3.97B3.69B
Depreciation & Amortization867M1.07B984M997M981M
EBITDA2.19B(1.76B)1.73B1.12B766M
EBITDA Margin18.0%-17.5%16.7%10.5%6.8%
Operating Income1.35B(2.85B)707M14M(308M)
Operating Margin11.1%-28.3%6.8%0.1%-2.7%
Interest Income14M19M69M67M52M
Interest Expense207M413M508M408M290M
Other Income / Expenses(234M)(403M)(465M)(303M)(197M)
Income Before Tax1.12B(3.25B)242M(289M)(505M)
Pre-Tax Margin9.2%-32.3%2.3%-2.7%-4.5%
Income Tax Expense83M(135M)61M37M395M
Net Income1.28B(2.43B)2.66B(649M)(957M)
Net Margin10.6%-24.2%25.6%-6.1%-8.5%
EPS (Basic)2.56(4.83)5.25(1.27)(1.75)
EPS (Diluted)2.53(4.83)5.23(1.27)(1.75)
Weighted Avg Shares502M504M506M510M513M
Weighted Avg Shares (Diluted)508M504M506M510M513M

Baxter International Inc.

NYSE:BAX

Intrinsic Alpha fair value

Locked

Current Price

$26.16

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.